Generics Industry News Search
 |
|
|
|
|
|
|
September 2004 News Archive |
|
|
| |
|
Sept. 1, 2004--IMPAX Laboratories, Inc. (NASDAQ:IPXL) today announced that the District Court of Wilmington, Delaware, has ruled that Aventis Pharmaceutical's patent 5,527,814 related to the use of Rilutek(R) for the treatment of amyotrophic lateral sclerosis ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sept. 8, 2004--IMPAX Laboratories, Inc. (Nasdaq:IPXL) announced today that its Omeprazole Delayed Release Capsules 20mg have been commercially launched by Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA). Omeprazole...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Fort Lee, New Jersey…September 13, 2004…Alpharma Inc. (NYSE:ALO), a leading global generic pharmaceutical company, today announced it has filed a motion requesting that the Court of Appeals for the District of Columbia vacate its stay order issued in Apotex v....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IRVINE, Calif., Sept. 10 - Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) today announced that it has received approval from the Office of Generic Drugs of the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) for ciprofloxacin tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ARLINGTON, Va., Sept. 15 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) today praised the Food and Drug Administration (FDA) for holding a public forum to discuss the science supporting generic biopharmaceuticals, and urged the agency to move forward to accelerate the approval of affordable biopharmaceuticals. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Fort Lee, New Jersey…September 17, 2004…Alpharma Inc. (NYSE:ALO), a leading global generic pharmaceutical company, today announced that the Court of Appeals for the District of Columbia has vacated its stay order regarding a launch of gabapentin capsules issued in Apotex v. the Food and Drug Administration (FDA). ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
BS Regional Bureau in Ahmedabad | September 17, 2004. Ahmedabad-based pharmaceutical major Zydus Cadila Healthcare Ltd has made a foray into the lucrative French generics market with the launch of 43 generics there....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
MIAMI - September 21, 2004 - IVAX Corporation (AMEX: IVX, LSE: IVX.L) announced today that its subsidiary, IVAX Pharmaceuticals, Inc., will distribute, in the United States, Amoxicillin/Clavulanate Potassium 600 mg/42.9 mg/5 mL for oral suspension,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Exeter, NH, September 21, 2004 - Bentley Pharmaceuticals, Inc. (NYSE: BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, announced today that three of its Spanish subsidiaries (Laboratorios Belmac, Davur and Rimafar)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Fort Lee, New Jersey…September 22, 2004…Alpharma Inc. today announced that Pfizer Pharmaceutical Co. (Pfizer) has filed a motion for a preliminary injunction in the District Court for the District for New Jersey seeking to enjoin the sale of the Company's gabapentin product. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jerusalem, Israel, September 22, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Cetirizine Hydrochloride Tablets,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
HAYWARD, Calif.--(BUSINESS WIRE)--Sept. 28, 2004--IMPAX Laboratories, Inc. (Nasdaq:IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the Company's Abbreviated New Drug Application (ANDA) for a generic version of OxyContin(R) (Oxycodone Hydrochloride) ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PITTSBURGH, Sept. 29 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced that the U.S. Food and Drug Administration has granted final approval for Mylan Pharmaceuticals' Abbreviated New Drug Application for Bromocriptine Mesylate Tablets USP, 2.5 mg. Bromocriptine Tablets are the generic version of Novartis Pharmaceuticals, Parlodel(R) Tablets....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Princeton, NJ - September 30, 2004 Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Clorazepate Dipotassium Tablets USP, 3.75 mg, 7.5 mg, and 15 mg. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
WOODCLIFF LAKE, N.J., Sept. 30 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for its application to manufacture and market a generic version of Watson Laboratories,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Washington, D.C., September 30, 2004 (PAHO)-The Pan American Health Organization (PAHO) seeks to promote consistent policies for the use of generic medicines in the Americas to increase the availability and use of quality basic health...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
